GNMSF:OTCMKTS
Genmab
367,00 US$
0,00%
(0,00) 1K
9-okt, 10:28:36 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoGNMSF tikeri uchun statistika yaratilmoqda...
Bozor kapitali
22,76 mlrd
Oʻrtacha hajm
1,37 ming
Hajmi
180,00
52 haftalik eng yuqori
396,97 US$
52 haftalik eng past
232,50 US$
Beta
0,73
Muomaladagi aksiyalar
62,41 mln
Xodimlar soni
3 ming
Bozor kapitali
22,76 mlrd
Oʻrtacha hajm
1,37 ming
Hajmi
180,00
52 haftalik eng yuqori
396,97 US$
52 haftalik eng past
232,50 US$
Beta
0,73
Muomaladagi aksiyalar
62,41 mln
Xodimlar soni
3 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TipRanks
·
13 soat oldin
Genmab Reports USD 4.2 Billion in Q3 2026 DARZALEX Net Sales
Profil
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Genmab haqida
CEOJan G. J. van de Winkel
Xodimlar soni3,12 ming
Asos solingan11-iyn, 1998
Bosh ofislar-
Sektor-
Veb-saytgenmab.com